Key result
This comprehensive review discusses the history of fibrinolysis, available plasminogen activators, and recommendations for thrombolytic therapy in acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
This review provides a comprehensive overview of the endogenous fibrinolytic system, available plasminogen activators, and recommendations for thrombolytic therapy in acute myocardial infarction.
In the first part of this comprehensive review of thrombolytic therapy in clinical medicine, we begin with a brief history of fibrinolysis, followed by a review of the components of die endogenous fibrinolytic system and the currently available plasminogen activators. An in-depth examination of thrombolysis in treatment of acute myocardial infarction follows, Including recommendations for management based on available clinical trial data. New developments in thrombolytic therapy are also discussed.
No takes yet. Share an insight, caveat, or question.
Bell et al. (1993) conducted a review in Acute myocardial infarction. Thrombolytic therapy was evaluated. This comprehensive review discusses the history of fibrinolysis, available plasminogen activators, and recommendations for thrombolytic therapy in acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: